Login / Signup

Recommendations on deprescribing of bisphosphonates in osteoporosis guidelines: a systematic review.

Ditte Beck JepsenEmilie Sofie BergenJeffrey PanEveline P van PoelgeestAbdiaziz OsmanAlaa BurghleJesper RygWade ThompsonCarina Lundby
Published in: European geriatric medicine (2023)
Bisphosphonate deprescribing recommendations in osteoporosis guidelines were primarily framed as drug holidays, with limited guidance on how to make individualized deprescribing decisions based on individual health context. This suggests a need for additional focus on deprescribing in osteoporosis guidelines.
Keyphrases
  • clinical practice
  • postmenopausal women
  • bone mineral density
  • public health
  • mental health
  • body composition
  • adverse drug